Free Trial
NASDAQ:BBLGW

Bone Biologics (BBLGW) Stock Price, News & Analysis

Bone Biologics logo
$13.50 0.00 (0.00%)
As of 05/23/2025

About Bone Biologics Stock (NASDAQ:BBLGW)

Key Stats

Today's Range
$13.50
$13.50
50-Day Range
$13.50
$20.20
52-Week Range
$3.00
$95.04
Volume
57 shs
Average Volume
2,005 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Receive BBLGW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

BBLGW Stock News Headlines

BBLG Entering Critical Stage in Good Shape
BBLG in Good Shape as Testing Continues
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Tellgen Corporation (300642.SZ)
BBLG: Controls Costs and Advances Trials
Bone Biologics Corp Warrants (BBLGW)
See More Headlines

BBLGW Stock Analysis - Frequently Asked Questions

Bone Biologics' stock was trading at $40.00 on January 1st, 2025. Since then, BBLGW shares have decreased by 66.3% and is now trading at $13.50.
View the best growth stocks for 2025 here
.

Bone Biologics shares reverse split on the morning of Wednesday, June 7th 2023. The 1-30 reverse split was announced on Wednesday, June 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of BBLGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBLGW
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:BBLGW) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners